SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-07-005583
Filing Date
2007-03-14
Accepted
2007-03-14 07:00:39
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED 12/31/06 v25967e10vk.htm 10-K 957463
2 AMENDED 2000 BROAD BASED EQUITY INCENTIVE PLAN v25967exv10w3.htm EX-10.3 82906
3 AMENDED 2002 BROAD BASED EQUITY INCENTIVE PLAN v25967exv10w4.htm EX-10.4 62312
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM v25967exv23w1.htm EX-23.1 1858
5 CERTIFICATION OF CEO SECTION 302 OF SARBANES OXLEY v25967exv31w1.htm EX-31.1 9216
6 CERTIFICATION OF CFO SECTION 302 OF SARBANES OXLEY v25967exv31w2.htm EX-31.2 9351
7 CERTIFICATION OF CEO AND CFO SECTION 906 SARBANES OXLEY v25967exv32.htm EX-32 6037
8 GRAPHIC v25967v2596701.gif GRAPHIC 8534
  Complete submission text file 0000950134-07-005583.txt   1142322
Mailing Address
Business Address 3005 FIRST AVENUE SEATTLE WA 98121 206254545
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30681 | Film No.: 07692143
SIC: 2834 Pharmaceutical Preparations